Characteristics of patients (N = 47) | |
---|---|
Median age (years) | 59 (Range: 35–75) |
GOG Performans status 0 | 40 (85%) |
≥ 1 | 7 (15%) |
Histologic type | Â |
Serous adenocarcinoma | Â |
Well differentiated | 19 (40%) |
Moderately/poorly differentiated | 20 (43%) |
Endometrioid adenocarcinoma | 5 (11%) |
Mixed epithelial carcinoma | 2 (4%) |
Clear cell carcinoma | 1 (2%) |
Visible residual macroscopic disease | Â |
Yes | 20 (43%) |
No | 27 (57%) |
Induction Chemotherapy (paclitaxel – carboplatin regimen) | 31 (66%) |
Initial surgery | 16 (44%) |
Second look surgery | 16/16* (100%) |
Total number of i.v. cycles of chemotherapy | 6 (Range:5–8) |